Daniel P. Ball

Daniel P. Ball

Auto-generated profile, based on publicly available information

Daniel P. Ball

Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2019 in Science
Verified
Journal Article
Open access
PDF file
ACAshley J. Chui
Ashley J. Chui
MOMarian C. Okondo
Marian C. Okondo
SRSahana D. Rao
Sahana D. Rao
KGKuo Gai
Kuo Gai
AGAndrew R. Griswold
Andrew R. Griswold
DBDaniel A. Bachovchin
Daniel A. Bachovchin
Degradation triggers the alarm: Inflammasomes are multiprotein complexes that orchestrate proinflammatory cytokine secretion and cell death. Proteases such as anthrax lethal factor can activate an inflammasome known as NLRP1B, but the mechanism for this activation has been unclear. Chui et al. used genome-wide knockout screens to show that proteolysis of NLRP1B by lethal factor induces proteasomal degradation of the amino-terminal domains of NLRP1B and eventual cell death. Sandstrom et al. found that degradation of the amino-terminal domains of NLRP1B resulted in the release of a carboxyl-terminal fragment that activates caspase-1. This process, called “functional degradation,” allows the immune system to detect pathogen-associated activities, much as it recognizes pathogen-associated antigens. Science , this issue p. 82 , p. eaau1330

1 October 2020 in Cell Reports
Verified
Journal Article
Open access
ACAshley J. Chui
Ashley J. Chui
AGAndrew R. Griswold
Andrew R. Griswold
CTCornelius Y. Taabazuing
Cornelius Y. Taabazuing
EOElizabeth L. Orth
Elizabeth L. Orth
KGKuo Gai
Kuo Gai
DBDaniel A. Bachovchin
Daniel A. Bachovchin
Several cytosolic pattern-recognition receptors (PRRs) form multiprotein complexes called canonical inflammasomes in response to intracellular danger signals. Canonical inflammasomes recruit and activate caspase-1 (CASP1), which in turn cleaves and activates inflammatory cytokines and gasdermin D (GSDMD), inducing pyroptotic cell death. Inhibitors of the dipeptidyl peptidases DPP8 and DPP9 (DPP8/9) activate both the human NLRP1 and CARD8 inflammasomes. NLRP1 and CARD8 have different N-terminal regions but have similar C-terminal regions that undergo autoproteolysis to generate two non-covalently associated fragments. Here, we show that DPP8/9 inhibition activates a proteasomal degradation pathway that targets disordered and misfolded proteins for destruction. CARD8’s N terminus contains a disordered region of ~160 amino acids that is recognized and destroyed by this degradation pathway, thereby freeing its C-terminal fragment to activate CASP1 and induce pyroptosis. Thus, CARD8 serves as an alarm to signal the activation of a degradation pathway for disordered and misfolded proteins.

25 November 2022 in Science Immunology
Verified
Journal Article
Closed access
DBDaniel P. Ball
Daniel P. Ball
LTLydia P. Tsamouri
Lydia P. Tsamouri
AWAlvin E. Wang
Alvin E. Wang
HHHsin-Che Huang
Hsin-Che Huang
CWCharles D. Warren
Charles D. Warren
DBDaniel A. Bachovchin
Daniel A. Bachovchin
The danger signals that activate the NLRP1 inflammasome have not been established. Here, we report that the oxidized, but not the reduced, form of thioredoxin-1 (TRX1) binds to NLRP1. We found that oxidized TRX1 associates with the NACHT-LRR region of NLRP1 in an ATP-dependent process, forming a stable complex that restrains inflammasome activation. Consistent with these findings, patient-derived and ATPase-inactivating mutations in the NACHT-LRR region that cause hyperactive inflammasome formation interfere with TRX1 binding. Overall, this work strongly suggests that reductive stress, the cellular perturbation that will eliminate oxidized TRX1 and abrogate the TRX1-NLRP1 interaction, is a danger signal that activates the NLRP1 inflammasome.

14 May 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JHJeffrey C. Hsiao
Jeffrey C. Hsiao
ANAtara R. Neugroschl
Atara R. Neugroschl
ACAshley J. Chui
Ashley J. Chui
CTCornelius Y. Taabazuing
Cornelius Y. Taabazuing
AGAndrew R. Griswold
Andrew R. Griswold
DBDaniel A. Bachovchin
Daniel A. Bachovchin
CARD8 is a pattern-recognition receptor that forms a caspase-1-activating inflammasome. CARD8 undergoes constitutive autoproteolysis, generating an N-terminal (NT) fragment with a disordered region and a ZU5 domain and a C-terminal (CT) fragment with UPA and CARD domains. Dipeptidyl peptidase 8 and dipeptidyl peptidase 9 inhibitors, including Val-boroPro, accelerate the degradation of the NT fragment via a poorly characterized proteasome-mediated pathway, thereby releasing the inflammatory CT fragment from autoinhibition. Here, we show that the core 20S proteasome, which degrades disordered and misfolded proteins independent of ubiquitin modification, controls activation of the CARD8 inflammasome. In unstressed cells, we discovered that the 20S proteasome degrades just the NT disordered region, leaving behind the folded ZU5, UPA, and CARD domains to act as an inhibitor of inflammasome assembly. However, in Val-boroPro–stressed cells, we show the 20S proteasome degrades the entire NT fragment, perhaps due to ZU5 domain unfolding, freeing the CT fragment from autoinhibition. Taken together, these results show that the susceptibility of the CARD8 NT domain to 20S proteasome-mediated degradation controls inflammasome activation.

1 February 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
QCQifeng Chen
Qifeng Chen
AWAlvin Wang
Alvin Wang
DCDominic J. Covelli
Dominic J. Covelli
ABAbir Bhattacharjee
Abir Bhattacharjee
QWQinghui Wang
Qinghui Wang
DBDaniel A. Bachovchin
Daniel A. Bachovchin